$240.33 +3.12 (%) Actavis PLC - NYSE

Oct. 24, 2014 | 04:00 PM

Partner Headlines

  1. Stock Charts Show Stocks' Health, Optimal Buy Point

    IBD | Oct. 23, 2014 | 17:54PM EST
  2. Illumina Breaks Out Of Double-Bottom Base

    IBD | Oct. 22, 2014 | 17:01PM EST
  3. Report: Actavis, Sanofi To Bid On Over-The-Counter Drug Maker

    Benzinga | Oct. 20, 2014 | 20:15PM EST
  4. Benzinga's M&A Chatter for Monday October 20, 2014

    Benzinga | Oct. 20, 2014 | 19:27PM EST
  5. Alexion: Keeping Up The Suspense Ahead Of Q3 Earnings

    IBD | Oct. 20, 2014 | 18:01PM EST
  6. Akorn Finds Institutional Support In Base

    IBD | Oct. 17, 2014 | 18:36PM EST
  7. Will Activis Win Competition For Allergan's Affection?

    Benzinga | Oct. 16, 2014 | 11:10AM EST
  8. Actavis Confirms Generic Quillivant XR® Patent Challenge

    Benzinga | Oct. 16, 2014 | 08:09AM EST
  9. AbbVie Board To Shareholders: Vote No On Shire Buy

    IBD | Oct. 16, 2014 | 00:52AM EST
  10. Stocks Pare Losses; Netflix Plunges After Hours

    IBD | Oct. 15, 2014 | 17:12PM EST
  11. Stocks Slump Again Heading Into Close

    IBD | Oct. 15, 2014 | 15:29PM EST
  12. Drug Analysts Mull End Of 'Double Irish' Loophole

    IBD | Oct. 14, 2014 | 13:10PM EST
  13. IBD 50: Medical, Internet Companies Top Q3 Estimates

    IBD | Oct. 13, 2014 | 19:15PM EST
  14. Patents, Taxes Lift Drug M&A

    IBD | Oct. 10, 2014 | 19:05PM EST
  15. IBD 50: Medical, Internet Companies Top Q3 Profit Estimates

    IBD | Oct. 10, 2014 | 18:45PM EST
  16. Drugmaker M&A Goes On, With Or Without Tax Inversions

    IBD | Oct. 10, 2014 | 17:37PM EST
  17. Indexes Slammed As Oil Prices, Stocks Sink

    IBD | Oct. 9, 2014 | 17:05PM EST
  18. Allergan Steeply Raises Guidance, Taunts Valeant

    IBD | Oct. 9, 2014 | 11:56AM EST
  19. Video: 3 Big Cap Biotechs Bucking Market Correction

    IBD | Oct. 8, 2014 | 17:49PM EST
  20. Stock Futures Aim For A Bounce; Symantec Up On Split Reports

    IBD | Oct. 8, 2014 | 09:01AM EST
  21. #PreMarket Primer: Wednesday, October 8: IMF Cuts Global Growth Prospects, Puts A Damper On Wall Street

    Benzinga | Oct. 8, 2014 | 08:19AM EST
  22. Benzinga's M&A Chatter for Tuesday October 7, 2014

    Benzinga | Oct. 7, 2014 | 20:16PM EST
  23. Salix, Actavis Among Big Cap Pharmas In Merger Mambo

    IBD | Oct. 7, 2014 | 19:33PM EST
  24. Allergan deal buzz intensifies

    IBD | Oct. 7, 2014 | 18:49PM EST
  25. Actavis Finds Rx To Grow On Busy Drugmaker M&A Scene

    IBD | Oct. 7, 2014 | 18:33PM EST
  26. Actavis, Jazz, Novo Lead Top World Stocks List

    IBD | Oct. 7, 2014 | 18:08PM EST
  27. Dow Suffers Largest Daily Decline Since July, S&P 500 At 8-Week Lows On Global Growth Concerns

    Benzinga | Oct. 7, 2014 | 16:52PM EST
  28. Allergan, Inc. Spikes On Renewed Interest From Actavis PLC

    Benzinga | Oct. 7, 2014 | 15:50PM EST
  29. Actavis expands antibiotics

    IBD | Oct. 6, 2014 | 18:45PM EST
  30. Generics Firms Step Up Their Game In Branded Drugs

    IBD | Oct. 6, 2014 | 18:08PM EST
  31. Markets Begin The Week On A Losing Note Ahead Of Earnings Kick Off, Fed Minutes

    Benzinga | Oct. 6, 2014 | 16:45PM EST
  32. EZchip Falls On Lowered Sales Forecast; Durata Therapeutics Shares Jump

    Benzinga | Oct. 6, 2014 | 15:27PM EST
  33. U.S. Stocks Turn Red; CareFusion Shares Surge On Announcement Of Acquisition By Becton, Dickinson

    Benzinga | Oct. 6, 2014 | 14:00PM EST
  34. Markets Open Higher; Hewlett-Packard Plans To Split Into Two Companies

    Benzinga | Oct. 6, 2014 | 10:58AM EST
  35. Actavis Expands Antibiotics Presence With Durata Buy

    IBD | Oct. 6, 2014 | 10:58AM EST
  36. Benzinga's Volume Movers

    Benzinga | Oct. 6, 2014 | 10:25AM EST
  37. Stocks Hitting 52-Week Highs

    Benzinga | Oct. 6, 2014 | 10:15AM EST
  38. Morning Market Movers

    Benzinga | Oct. 6, 2014 | 09:42AM EST
  39. Gilead Among Top IBD 50 Stocks Heading Into Earnings

    IBD | Oct. 4, 2014 | 08:02AM EST
  40. Salix Bails On Tax Inversion

    IBD | Oct. 3, 2014 | 18:47PM EST
  41. Nasdaq, S&P 500 Aim For 50-Day Lines; Alexion Breaks Out

    IBD | Oct. 3, 2014 | 13:32PM EST
  42. Salix Cancels Tax Inversion, Opens Way For Buyers

    IBD | Oct. 3, 2014 | 11:11AM EST
  43. SALIX PHARMACEUTICALS

    IBD | Oct. 2, 2014 | 18:45PM EST
  44. Top Fund Buys: Chipotle, Allergan, Jazz, Gilead

    IBD | Oct. 2, 2014 | 18:25PM EST
  45. Actavis rival results positive

    IBD | Oct. 1, 2014 | 18:43PM EST
  46. Ardelyx Bowel Drug Could Rival Actavis' Linzess

    IBD | Oct. 1, 2014 | 12:10PM EST
  47. Ireland Exporters Look To Thursday's ECB Policy Vote

    IBD | Sep. 30, 2014 | 18:24PM EST
  48. Facebook Among 5 IBD 50 Stocks Holding Near Highs

    IBD | Sep. 27, 2014 | 08:02AM EST
  49. Meet 5 Top Stocks With Rising Earnings Estimates

    IBD | Sep. 26, 2014 | 08:02AM EST
  50. Benzinga's M&A Chatter for Wednesday September 24, 2014

    Benzinga | Sep. 24, 2014 | 21:09PM EST
Trading Center